Comparison of 22Mhz and 18Mhz High-frequency Probes for the Ultrasound Study of Temporal Arteries in Patients Suspected of Having Giant Cell Arteritis

NCT04204512 | Completed

• 1 other identifier: ECHORTON (29BRC19.0275)
• Study Type: observational
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

Evaluation of the structural features of temporal arteritis using two frequencies probes: 18 and 22Mhz.

Conditions

Giant Cell Arteritis

Keywords

ultrasound,; giant cell arteritis

Outcome Measures

Primary Outcomes (2)

• halo sign of temporal arteritis

  hypoechogenicity of the wall artery

  inclusion

• compression sign of of temporal arteritis

  persistent of increased inflammatory arteries wall

  inclusion

Secondary Outcomes (5)

• halo sign of carotid arteritis

  inclusion

• halo sign of subclavian arteritis

  inclusion

• halo sign of axillary arteritis

  inclusion

• other structural abnormalities in unilateral B mode

  inclusion

• other structural abnormalities in bilateral B mode

  inclusion

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

patients with suspicion of giant cell arteritis

You may qualify if:

• sedimentation rate\> 50 mm/h or recent unusual headache or unusual fever, recent visual trouble or jaw claudication, or induration temporal arteritis

You may not qualify if:

• previous diagnosis of giant cell arteritis and relapse of the giant cell arteritis and opposition to participate

Sponsors & Collaborators

• University Hospital, Brest: lead

Study Sites (1)

CHRU de Brest

Brest, 29609, France

Location

MeSH Terms

Conditions

Giant Cell Arteritis

Condition Hierarchy (Ancestors)

Vasculitis, Central Nervous System; Autoimmune Diseases of the Nervous System; Nervous System Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases; Arteritis; Vasculitis; Skin Diseases, Vascular; Skin Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 17, 2019
• First Posted: December 19, 2019
• Study Start: December 17, 2019
• Primary Completion: August 24, 2020
• Study Completion: August 24, 2020
• Last Updated: August 24, 2021

Record last verified: 2021-07

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: Data will be available beginning 18 month and ending five years following the end of study
• Access Criteria: Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.

Locations

FR (1)